Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2011-6-21
pubmed:abstractText
Activated monocytes/macrophages are known to release toxic materials. Identification of these materials is important for developing more effective treatments for inflammatory disorders where self attack occurs. We stimulated human monocytes and THP-1 cells with LPS/IFN? and measured the toxic effects of their conditioned media against differentiated human NT-2 cells. Their cytotoxicity, as measured by LDH release, was reduced by half when their conditioned media was passed through a 3kDa cutoff filter, indicating an equal division between high and low molecular weight materials. When the high molecular weight components tumor necrosis factor-? (TNF?), interleukin-1? (IL-1?), and IL-6 were removed from the conditioned medium by specific antibodies, the toxicity was reduced by 37-38%. When prostaglandin production was blocked by treatment with the COX inhibitors acetylsalicylic acid and ibuprofen, toxicity was reduced by 15-16%. When oxygen free radical production was blocked by the NADPH inhibitor diphenylene iodonium (DPI) the toxicity was reduced by 17-18%. Treatment with the nitric oxide scavenger carboxy-phenyl-tetramethylimidazolineoxyl-oxide, or the NOS inhibitor N(G)-monomethylene-l-arginine, attenuated the toxicity by about 20%. Removal of released glutamate by glutamate decarboxylase also attenuated the toxicity by 12-13%. In combination, these treatments reduced the toxicity by approximately 50% accounting for the low molecular weight component toxicity. About 10% of the overall toxicity, which was associated with the high molecular weight component, was not identified. Optimal antiinflammatory therapy may require combined suppression of these identified toxin-generating pathways as well as relatively minor pathways yet to be identified.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-phenyl-4,4,5,5-tetramethylimidazol..., http://linkedlifedata.com/resource/pubmed/chemical/6,7-dihydro-5H-pyrrolo(1,2-a)imidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic N-Oxides, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone, http://linkedlifedata.com/resource/pubmed/chemical/Glutamate Decarboxylase, http://linkedlifedata.com/resource/pubmed/chemical/Glutamic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma, http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/NADPH Oxidase, http://linkedlifedata.com/resource/pubmed/chemical/Neurotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type I, http://linkedlifedata.com/resource/pubmed/chemical/Nitrites, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/glutamate decarboxylase 2
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1872-6240
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier B.V. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
11
pubmed:volume
1400
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
99-111
pubmed:meshHeading
pubmed-meshheading:21640980-Analysis of Variance, pubmed-meshheading:21640980-Antibodies, pubmed-meshheading:21640980-Cell Line, Transformed, pubmed-meshheading:21640980-Cell Line, Tumor, pubmed-meshheading:21640980-Cyclic N-Oxides, pubmed-meshheading:21640980-Cyclooxygenase 1, pubmed-meshheading:21640980-Cyclooxygenase 2, pubmed-meshheading:21640980-Cytokines, pubmed-meshheading:21640980-Dinoprostone, pubmed-meshheading:21640980-Dose-Response Relationship, Drug, pubmed-meshheading:21640980-Glutamate Decarboxylase, pubmed-meshheading:21640980-Glutamic Acid, pubmed-meshheading:21640980-Humans, pubmed-meshheading:21640980-Imidazoles, pubmed-meshheading:21640980-Interferon-gamma, pubmed-meshheading:21640980-L-Lactate Dehydrogenase, pubmed-meshheading:21640980-Leukemia, Monocytic, Acute, pubmed-meshheading:21640980-Lipopolysaccharides, pubmed-meshheading:21640980-Molecular Weight, pubmed-meshheading:21640980-Monocytes, pubmed-meshheading:21640980-NADPH Oxidase, pubmed-meshheading:21640980-Neurotoxins, pubmed-meshheading:21640980-Nitric Oxide Synthase Type I, pubmed-meshheading:21640980-Nitrites, pubmed-meshheading:21640980-Pyrroles, pubmed-meshheading:21640980-RNA, Messenger, pubmed-meshheading:21640980-Teratocarcinoma
pubmed:year
2011
pubmed:articleTitle
Neurotoxic factors released by stimulated human monocytes and THP-1 cells.
pubmed:affiliation
Kinsmen Laboratory of Neurological Research, Vancouver, BC, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't